{"denoms":[{"counts":[{"groupId":"BG000","value":"725"},{"groupId":"BG001","value":"725"},{"groupId":"BG002","value":"1450"}],"units":"Participants"}],"groups":[{"description":"Oral netupitant/palonosetron (300 mg/0.50 mg) hard capsule with oral dexamethasone, both given on Day 1, prior to each scheduled chemotherapy cycle\n\nNetupitant and Palonosetron\n\nDexamethasone","id":"BG000","title":"Netupitant and Palonosetron Plus Dexamethasone"},{"description":"Oral palonosetron 0.50 mg (Aloxi) with oral dexamethasone both given on Day 1, prior to each scheduled chemotherapy cycle\n\nPalonosetron\n\nDexamethasone","id":"BG001","title":"Palonosetron Plus Dexamethasone"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.66","value":"53.7"},{"groupId":"BG001","spread":"10.65","value":"54.1"},{"groupId":"BG002","spread":"10.65","value":"53.9"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"711"},{"groupId":"BG001","value":"711"},{"groupId":"BG002","value":"1422"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"28"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"574"},{"groupId":"BG001","value":"579"},{"groupId":"BG002","value":"1153"}]}],"title":"White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"4"}]}],"title":"Black"},{"categories":[{"measurements":[{"groupId":"BG000","value":"101"},{"groupId":"BG001","value":"103"},{"groupId":"BG002","value":"204"}]}],"title":"Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"46"},{"groupId":"BG001","value":"36"},{"groupId":"BG002","value":"82"}]}],"title":"Hispanic"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"7"}]}],"title":"Other"}],"paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"participants"}],"populationDescription":"Safety population ie patients receiving either netupitant/palonosetron combination or palonosetron, both plus dexamethasone"}